Monoclonal antibodies should become the best selling drug in the world

While mRNA vaccines are currently the best selling drug in the world, they are not that safe and can lead to death and disability.  Monoclonal antibodies are actually the #1 intervention for COVID because they are both safe and effective.  Unfortunately for monoclonals, their broader adoption is held back by 2 false narratives:

  1. COVID vaccines are safe.
  2. Monoclonal antibodies duplicate what vaccines do.

Should the political winds change and my heretical viewpoints become mainstream, monoclonal antibodies could generate $200B+ every year.  Regeneron Pharmaceuticals, which has rights to the #1 monoclonal antibody treatment, has a market cap of only $69B.

Continue reading